ATE22439T1 - 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. - Google Patents
2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.Info
- Publication number
- ATE22439T1 ATE22439T1 AT82102908T AT82102908T ATE22439T1 AT E22439 T1 ATE22439 T1 AT E22439T1 AT 82102908 T AT82102908 T AT 82102908T AT 82102908 T AT82102908 T AT 82102908T AT E22439 T1 ATE22439 T1 AT E22439T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- phenyl
- substituted
- substituted phenyl
- amino
- Prior art date
Links
- -1 (SUBSTITUTED SULFONYL)AMINO Chemical class 0.000 title abstract 7
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 title 1
- 150000001539 azetidines Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 9
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- 229910003827 NRaRb Inorganic materials 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002071 phenylalkoxy group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 150000003952 β-lactams Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25267281A | 1981-04-09 | 1981-04-09 | |
| EP82102908A EP0062876B1 (en) | 1981-04-09 | 1982-04-05 | 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)azetidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE22439T1 true ATE22439T1 (de) | 1986-10-15 |
Family
ID=22957021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT82102908T ATE22439T1 (de) | 1981-04-09 | 1982-04-05 | 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0062876B1 (en, 2012) |
| JP (1) | JPS57179156A (en, 2012) |
| AT (1) | ATE22439T1 (en, 2012) |
| AU (1) | AU561650B2 (en, 2012) |
| CA (1) | CA1246572A (en, 2012) |
| DE (1) | DE3273405D1 (en, 2012) |
| DK (1) | DK162582A (en, 2012) |
| ES (3) | ES511238A0 (en, 2012) |
| GR (1) | GR76486B (en, 2012) |
| HU (1) | HU187568B (en, 2012) |
| IE (1) | IE52938B1 (en, 2012) |
| IL (1) | IL65407A0 (en, 2012) |
| NZ (1) | NZ199981A (en, 2012) |
| PH (1) | PH23122A (en, 2012) |
| PT (1) | PT74730B (en, 2012) |
| ZA (1) | ZA821768B (en, 2012) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1272726C (en) * | 1982-01-04 | 1990-08-14 | 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines | |
| US4548747A (en) * | 1983-05-02 | 1985-10-22 | E. R. Squibb & Sons, Inc. | 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones |
| US4534896A (en) * | 1983-06-13 | 1985-08-13 | E. R. Squibb & Sons, Inc. | 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid) |
| US4587051A (en) * | 1983-07-18 | 1986-05-06 | E. R. Squibb & Sons, Inc. | Desulfonation process for preparing 2-azetidinones |
| US4584132A (en) * | 1983-08-09 | 1986-04-22 | Hoffmann-La Roche Inc. | 1-(N-phosphinylcarbamoyl) β-lactam antibacterial agents |
| US4559335A (en) * | 1983-10-03 | 1985-12-17 | E. R. Squibb & Sons, Inc. | 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones |
| US4576749A (en) * | 1983-10-03 | 1986-03-18 | E. R. Squibb & Sons, Inc. | 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones |
| US4831130A (en) * | 1984-05-31 | 1989-05-16 | Hoffmann-La Roche Inc. | β-lactam antibacterial agents |
| EG18314A (en) * | 1985-09-26 | 1993-02-28 | Squibb & Sons Inc | Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines |
| US4743685A (en) * | 1985-09-26 | 1988-05-10 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines |
| AU7541487A (en) * | 1986-05-23 | 1987-12-22 | Upjohn Company, The | N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams |
| US4801705A (en) * | 1986-06-23 | 1989-01-31 | E. R. Squibb & Sons, Inc. | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines |
| CA1317298C (en) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| US4762922A (en) * | 1987-07-01 | 1988-08-09 | Squibb Corporation | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| US4772693A (en) * | 1987-07-01 | 1988-09-20 | E. R. Squibb & Sons, Inc. | 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines |
| US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| FI20031113A7 (fi) * | 2003-07-29 | 2005-01-30 | Outokumpu Oy | Menetelmä ja laitteisto leijupetiuunin arinalta poistettavan materiaalin jäähdyttämiseksi |
| US7511159B2 (en) * | 2003-12-25 | 2009-03-31 | Ono Pharmaceutical Co., Ltd. | Azetidine ring compounds and drugs comprising the same |
| AU2012233003B2 (en) * | 2005-12-07 | 2014-12-18 | Basilea Pharmaceutica Ag | Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| DK1965798T3 (da) | 2005-12-07 | 2011-11-28 | Basilea Pharmaceutica Ag | Nyttige monobactam-antibiotika |
| EP2379546A1 (en) | 2008-12-19 | 2011-10-26 | Pfizer Inc. | Monocarbams |
| KR20230175175A (ko) * | 2020-11-30 | 2023-12-29 | 소프로시네 파마슈티칼스 리미티드 | 알코올 사용 장애(Alcohol Use Disorder)를 치료하기 위한 화합물 및 방법 |
| WO2022261441A2 (en) | 2021-06-10 | 2022-12-15 | Sophrosyne Pharmaceuticals Limited | Crystalline forms of aldh2 modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2559307C2 (de) * | 1975-12-31 | 1984-05-24 | Rheinhold & Mahla Gmbh, 6800 Mannheim | Verfahren und Vorrichtung zum Verkleben zweier Materialbahnen |
| US4195021A (en) * | 1977-10-26 | 1980-03-25 | Eli Lilly And Company | 1,3-Disubstituted 2-azetidinone antibitotics |
| DE3069587D1 (en) * | 1979-06-08 | 1984-12-13 | Takeda Chemical Industries Ltd | 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof |
-
1982
- 1982-03-11 NZ NZ199981A patent/NZ199981A/en unknown
- 1982-03-15 CA CA000398357A patent/CA1246572A/en not_active Expired
- 1982-03-16 GR GR67605A patent/GR76486B/el unknown
- 1982-03-16 AU AU81557/82A patent/AU561650B2/en not_active Ceased
- 1982-03-16 ZA ZA821768A patent/ZA821768B/xx unknown
- 1982-04-02 IL IL65407A patent/IL65407A0/xx not_active IP Right Cessation
- 1982-04-02 IE IE781/82A patent/IE52938B1/en not_active IP Right Cessation
- 1982-04-05 AT AT82102908T patent/ATE22439T1/de not_active IP Right Cessation
- 1982-04-05 DE DE8282102908T patent/DE3273405D1/de not_active Expired
- 1982-04-05 EP EP82102908A patent/EP0062876B1/en not_active Expired
- 1982-04-07 DK DK162582A patent/DK162582A/da not_active IP Right Cessation
- 1982-04-07 JP JP57057940A patent/JPS57179156A/ja active Granted
- 1982-04-07 ES ES511238A patent/ES511238A0/es active Granted
- 1982-04-08 PT PT74730A patent/PT74730B/pt not_active IP Right Cessation
- 1982-04-08 HU HU821091A patent/HU187568B/hu unknown
-
1983
- 1983-04-15 ES ES521479A patent/ES521479A0/es active Granted
- 1983-04-15 ES ES521480A patent/ES8405369A1/es not_active Expired
-
1985
- 1985-08-30 PH PH32722A patent/PH23122A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES8307741A1 (es) | 1983-07-01 |
| ES521480A0 (es) | 1984-06-01 |
| JPH0372616B2 (en, 2012) | 1991-11-19 |
| IE820781L (en) | 1982-10-09 |
| PT74730A (en) | 1982-05-01 |
| ES8405368A1 (es) | 1984-06-01 |
| EP0062876B1 (en) | 1986-09-24 |
| IL65407A0 (en) | 1982-07-30 |
| DE3273405D1 (en) | 1986-10-30 |
| EP0062876A1 (en) | 1982-10-20 |
| DK162582A (da) | 1982-10-10 |
| HU187568B (en) | 1986-01-28 |
| PH23122A (en) | 1989-05-05 |
| ES8405369A1 (es) | 1984-06-01 |
| IE52938B1 (en) | 1988-04-13 |
| ZA821768B (en) | 1983-01-26 |
| GR76486B (en, 2012) | 1984-08-10 |
| ES521479A0 (es) | 1984-06-01 |
| CA1246572A (en) | 1988-12-13 |
| JPS57179156A (en) | 1982-11-04 |
| NZ199981A (en) | 1985-08-16 |
| AU8155782A (en) | 1982-10-14 |
| AU561650B2 (en) | 1987-05-14 |
| PT74730B (en) | 1983-10-25 |
| ES511238A0 (es) | 1983-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE22439T1 (de) | 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. | |
| SE8604089D0 (sv) | 2-oxo-1-//(substituerad sulfonyl)amino/karbonyl/-azetidiner | |
| FR2416225A1 (fr) | Derives de la 4-amino-3 sulfamido-pyridine, leur procede de preparation et leur application comme diuretiques | |
| DE3770644D1 (de) | Monosulfactame. | |
| DE3781337D1 (de) | 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine. | |
| DE3566664D1 (de) | Substituted pyrazolin-5-one | |
| DE3783159D1 (de) | 2-oxo-1-(substituierte phosphorigsaeure)azetidine. | |
| GR75173B (en, 2012) | ||
| MX9302388A (es) | Oxazolidinonas fungicidas y composicion fungicida que las contiene | |
| ATE46516T1 (de) | Phosphonamidthioate-insektizide. | |
| ATE24181T1 (de) | 2-oxo-1-(thiophosphon- oder thiophosphinsaeure)azetidine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |